No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
195 |
4. Check minimum number of eventsNone |
195 |
5. Include endpointsNone |
195 |
6. Filter based on genotype QC (FinnGen only) |
195 |
Control definitions (FinnGen only)
- Control exclude
- H7_VITREOUS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H44
- Name in latin
- Degeneratio bulbi oculi
Similar endpoints
↥List of similar endpoints to
Degenerative conditions of globe
based on the number of shared cases.
Similar with more cases:
- Disorders of globe
- Disorders of vitreous body and globe
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3241 | 1579 | 1622 |
| Only index persons | 2177 | 1098 | 1079 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.05 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 71.66 | 76.48 | 66.95 |
| Only index persons | 69.72 | 76.15 | 63.17 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 195 | 71 | 124 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | 65.99 | 65.20 | 66.44 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 177
- Matched controls
- 1768
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H44.5
ICD-10 Finland
Degenerated conditions of globe
+∞
190.9
147
*
114
Kela drug reimbursment
Glaucoma
20.1
59.4
100
107
S01ED51
ATC
timolol, combinations; ophthalmic
21.2
54.6
87
77
S01ED01
ATC
timolol; ophthalmic
21.6
42.7
65
46
S01EC01
ATC
acetazolamide; systemic
39.2
42.1
53
19
S01EX03
ATC
NA
26.7
40.0
56
30
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
39.6
36.0
45
15
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
116.1
35.3
37
*
S01EE01
ATC
latanoprost; ophthalmic
12.0
28.3
55
64
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
23.4
27.2
39
21
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
249.4
22.1
22
*
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
12.1
21.8
41
43
S01EC03
ATC
dorzolamide; ophthalmic
26.3
21.2
29
13
H43.1
ICD-10 Finland
Vitreous haemorrhage
223.9
20.0
20
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.8
19.5
63
153
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
4.4
19.3
107
457
H54.4
ICD-10 Finland
Blindness, monocular
+∞
19.1
18
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.4
19.0
105
441
37861
ICD-8 Finland
Other diseases of eye, Phthisis et degeneratio bulbi
+∞
15.9
15
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
18.3
15.8
24
15
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.2
15.2
52
131
XCK00
NOMESCO Finland
Perimetry
8.2
14.8
34
50
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
87.5
14.8
16
*
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
+∞
14.8
14
*
CDC00
NOMESCO Finland
Enucleation of eye
+∞
14.8
14
*
S01EA02
ATC
dipivefrine; ophthalmic
30.1
14.6
19
7
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
13.0
14.3
25
22
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
9.9
13.9
28
33
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
20.3
13.7
20
11
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
13.7
13
*
S01EC04
ATC
brinzolamide; ophthalmic
10.7
13.5
26
28
S01FA01
ATC
atropine; ophthalmic
31.1
13.2
17
6
S01EB01
ATC
pilocarpine; ophthalmic
15.7
13.1
21
15
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
10.0
13.0
26
30
Z97.0
ICD-10 Finland
Presence of artificial eye
+∞
12.6
12
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
139.4
12.6
13
*
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
29.1
12.3
16
6
H43.8
ICD-10 Finland
Other disorders of vitreous body
32.5
11.8
15
5
A10AA01
ATC
NA
15.0
11.8
19
14
37514
ICD-8 Finland
Glaucoma, Chronicum absolutum s. fero absolutum dolorosum
+∞
11.6
11
*
H3603, E103
ICD-10 Finland
NA
127.9
11.6
12
*
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
127.9
11.6
12
*
CKD20
NOMESCO Finland
Removal of vitreous body substitute
127.9
11.6
12
*
H54.0
ICD-10 Finland
Blindness, binocular
116.6
10.5
11
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
+∞
10.5
10
*
A10AA02
ATC
NA
8.1
10.4
23
32
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
15.8
10.2
16
11
H16.0
ICD-10 Finland
Corneal ulcer
8.2
10.1
22
30
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
11.6
10.0
18
17
H34.8
ICD-10 Finland
Other retinal vascular occlusions
12.4
9.8
17
15
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
11.6
9.5
17
16
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
105.4
9.5
10
*
TCA15
NOMESCO Finland
Retrobulbar therapeutic injection into orbit
+∞
9.5
9
*
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
+∞
9.5
9
*
3604A
ICD-9 Finland
Disorders of the globe, Degenerated conditions of globe
+∞
9.5
9
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
8.5
9.4
20
26
S01EA03
ATC
apraclonidine; ophthalmic
12.4
9.3
16
14
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
38.8
9.1
11
*
H04AA01
ATC
glucagon; nasal, parenteral
15.1
8.8
14
10
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
15.1
8.8
14
10
H40.0
ICD-10 Finland
Glaucoma suspect
5.6
8.7
25
50
CKD15
NOMESCO Finland
Injection of vitreous substitute
94.3
8.5
9
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
13.9
8.0
13
10
H04.10
ICD-10 Finland
Dry eye syndrome
4.7
7.7
26
63
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
19.4
7.7
11
6
H26.2
ICD-10 Finland
Complicated cataract
26.3
7.7
10
*
Z94.0
ICD-10 Finland
Kidney transplant status
83.4
7.5
8
*
H54.1
ICD-10 Finland
Severe visual impairment, binocular
83.4
7.5
8
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
7.9
7.4
16
22
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
7.1
7.3
17
26
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
6.5
7.3
18
30
S01ED02
ATC
betaxolol; ophthalmic
9.4
7.2
14
16
S01EE05
ATC
tafluprost; ophthalmic
8.8
7.0
14
17
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
11.6
6.9
12
11
127
Kela drug reimbursment
Transplant complication
41.7
6.8
8
*
S01FA02
ATC
scopolamine; ophthalmic
23.5
6.7
9
*
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
12.9
6.7
11
9
S01BC03
ATC
diclofenac; ophthalmic
7.0
6.5
15
23
Z49.1
ICD-10 Finland
Extracorporeal dialysis
18.8
6.3
9
5
3651B
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]
18.8
6.3
9
5
CDC40
NOMESCO Finland
Evisceration of eye with insertion of prosthesis
+∞
6.3
6
*
H18.1
ICD-10 Finland
Bullous keratopathy
+∞
6.3
6
*
CKC20
NOMESCO Finland
Cryopexy of undetached retina
+∞
6.3
6
*
3643
FHL
Vitrectomy through pars Plana
+∞
6.3
6
*
CAW99
NOMESCO Finland
Other operation on orbit
+∞
6.3
6
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
27.7
6.3
8
*
H3603, E113
ICD-10 Finland
NA
27.7
6.3
8
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
8.2
6.2
13
17
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
5.6
6.2
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
158
2.48
5.07
2.8
6.1
2.1
1.3
mmol/l
0.63
25
124
73
464
1.92
4.39
3.1
2.2
75.9
75.6
nmol/l
0.04
65
394
21
91
2.47
3.31
3.5
6.9
25.2
24.1
mmol/l
0.67
21
86
6
7
8.79
3.28
1.5
2.0
—
—
—
0
0
27
132
2.21
3.26
3.6
2.8
4.2
6.5
ug/l
0.65
18
111
31
161
2.10
3.22
9.8
9.1
—
—
—
0
0
60
392
1.77
3.16
2.3
2.1
212.1
276.7
u/l
0.34
55
361
21
95
2.36
3.02
1.7
1.4
—
—
—
0
0
78
566
1.63
2.72
6.3
4.4
34.8
34.9
g/l
0.06
69
524
58
391
1.69
2.68
5.8
4.0
14.9
11.5
mg/mmol
0.21
42
242
23
116
2.11
2.58
10.7
4.1
0.6
1.8
mmol/l
1.12
17
85
83
622
1.58
2.49
14.1
6.6
1.2
1.2
mmol/l
0.33
71
514
23
118
2.08
2.48
11.0
4.1
5.7
5.7
kpa
0.11
23
111
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
41
2.78
2.32
3.5
2.1
0.3
0.3
u/ml
—
6
23
8
28
2.93
1.88
2.3
1.1
—
—
—
0
0
35
226
1.67
1.88
2.3
1.8
—
—
—
0
0
16
81
2.06
1.80
3.7
3.2
75.3
64.9
ml/min/173m2
—
6
33
15
75
2.08
1.75
7.7
3.9
25.5
24.6
mmol/l
0.49
15
75
5
13
3.92
1.72
3.2
2.3
—
—
—
0
0
73
568
1.46
1.71
12.2
5.5
1.2
1.2
mmol/l
0.59
65
512
7
25
2.86
1.66
1.6
1.6
—
—
—
0
0
5
14
3.64
1.62
1.2
1.4
—
—
—
0
0
5
14
3.64
1.62
1.8
1.7
—
—
—
0
0
5
14
3.64
1.62
1.6
1.4
—
—
—
0
0
5
14
3.64
1.62
1.0
1.6
9.6
16.7
u/l
—
5
14
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
5
15
3.39
1.53
1.8
1.7
—
—
—
0
0
5
16
3.18
1.44
1.0
1.1
—
—
—
0
0
5
16
3.18
1.44
1.8
1.6
—
—
—
0
0
5
16
3.18
1.44
1.8
1.6
—
—
—
0
0
12
60
2.07
1.41
2.4
2.0
—
—
—
0
0
66
520
1.41
1.41
2.3
1.9
89.2
92.9
pmol/l
0.29
36
250
109
1232
0.74
1.27
6.1
5.0
2.4
2.6
mmol/l
1.02
103
1102
11
56
2.02
1.24
2.4
1.8
—
—
—
0
0
71
581
1.35
1.18
4.8
4.3
36.5
55.0
ng/l
1.00
55
431
59
470
1.37
1.16
5.0
3.2
—
—
—
0
0
8
40
2.04
1.13
1.4
1.5
—
—
—
0
0
26
180
1.51
1.07
4.4
2.4
17.1
21.4
%
1.19
21
156
24
340
0.66
1.07
2.5
2.9
0.8
0.8
ug/l
0.11
16
227
46
357
1.38
1.05
2.8
2.0
3.1
3.4
mg/l
0.62
37
304
38
286
1.41
1.04
2.2
1.8
1160.3
1214.7
nmol/l
0.16
32
215
5
22
2.30
1.04
1.0
1.4
—
—
—
0
0
90
774
1.30
1.03
7.3
4.5
7.8
6.8
mmol/l
2.60
83
722
72
602
1.31
1.01
4.7
3.9
0.0
0.0
estimate
—
9
121
55
443
1.34
1.00
3.2
3.1
2.3
2.3
mmol/l
0.53
42
374
22
150
1.53
0.98
2.1
1.6
—
—
—
0
0
39
299
1.38
0.96
3.6
2.2
—
—
—
0
0
72
606
1.30
0.95
6.9
5.2
0.0
0.0
estimate
—
9
119
104
1160
0.78
0.95
5.2
4.0
1.4
1.3
mmol/l
1.42
93
1029
6
27
2.26
0.94
1.7
1.7
—
—
—
0
0
73
617
1.29
0.94
4.9
3.9
0.0
0.0
estimate
—
9
116
6
114
0.51
0.86
1.8
1.4
—
—
—
0
0
22
155
1.47
0.85
2.1
1.7
—
—
—
0
0
108
1190
0.79
0.84
5.7
4.4
1.3
1.4
mmol/l
1.20
97
1061
119
1080
1.26
0.82
25.7
16.1
36.9
39.6
%
1.10
64
720
109
1198
0.80
0.82
5.7
4.5
4.3
4.5
mmol/l
0.90
99
1082
8
48
1.69
0.79
1.9
2.6
—
—
—
0
0
99
886
1.24
0.75
4.2
3.6
15.2
15.0
pmol/l
0.19
87
766
108
976
1.24
0.75
8.0
7.0
91.0
79.9
u/l
0.51
103
911
39
474
0.78
0.68
5.2
4.4
24.3
22.0
%
0.41
25
236
34
272
1.30
0.65
1.7
1.6
1.7
1.4
mg/l
0.42
27
205
52
606
0.81
0.63
4.6
5.0
7.0
2.8
ug/l
0.40
46
526
111
1200
0.83
0.63
5.3
4.6
6.6
6.1
mmol/l
1.93
97
1063
43
357
1.26
0.63
4.6
4.1
0.0
0.0
estimate
—
8
112
13
88
1.51
0.62
1.5
1.3
—
—
—
0
0
5
30
1.68
0.62
1.6
1.1
—
—
—
0
0
24
185
1.34
0.59
33.9
24.8
1.9
1.2
inr
—
5
19
11
73
1.54
0.57
1.9
1.8
—
—
—
0
0
8
55
1.47
0.57
1.6
2.5
—
—
—
0
0
109
1171
0.84
0.53
19.7
14.8
69.4
76.4
ml/min/173m2
1.65
88
948
5
82
0.60
0.47
2.0
1.7
—
—
—
0
0
65
581
1.18
0.46
4.5
4.2
—
—
—
0
0
7
49
1.44
0.46
1.0
1.0
—
—
—
0
0
5
31
1.63
0.43
1.6
1.1
—
—
—
0
0
53
469
1.18
0.42
3.5
3.3
2143.6
1830.7
ng/l
0.18
45
384
5
32
1.58
0.42
1.2
1.5
—
0.1
—
0
12
56
498
1.17
0.42
4.9
4.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
3.9
—
—
—
0
0
5
34
1.48
0.40
1.2
1.3
—
—
—
0
0
5
35
1.44
0.39
1.4
1.2
—
—
—
0
0
25
207
1.24
0.39
3.5
2.7
0.3
1.1
e6/l
2.40
17
114
5
36
1.40
0.38
1.0
1.5
—
—
—
0
0
13
164
0.78
0.32
6.2
4.7
32.3
32.1
%
—
7
104
72
671
1.12
0.27
3.9
5.7
10.6
12.3
umol/l
0.84
64
633
23
199
1.18
0.25
3.7
2.9
0.9
1.6
e6/l
0.59
15
107
40
364
1.12
0.23
4.4
2.9
0.2
0.4
e6/l
0.37
34
275
128
1321
0.91
0.22
13.0
10.0
29.7
25.0
u/l
0.76
122
1260
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
3.7
—
57.3
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
5
43
1.17
0.21
1.4
4.7
—
3.9
—
0
6
5
43
1.17
0.21
1.4
4.7
49.4
241.4
mg/l
—
5
35
5
43
1.17
0.21
1.4
4.7
34.3
33.6
mg/l
—
5
36
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
111
1149
0.92
0.19
9.2
6.1
44.7
41.2
mmol/mol
2.22
101
1053
114
1101
1.09
0.19
5.3
4.3
2.1
2.0
mu/l
0.39
105
960
6
52
1.16
0.19
1.5
1.3
—
—
—
0
0
7
62
1.13
0.17
1.6
3.3
12.0
3125.7
u/ml
—
7
54
17
149
1.15
0.16
1.2
1.5
—
—
—
0
0
10
119
0.83
0.16
1.8
2.0
303.7
394.5
nmol/l
—
10
104
37
343
1.10
0.15
3.2
2.9
26576.0
8005.5
umol/l
0.49
31
281
70
671
1.07
0.13
3.2
2.8
—
—
—
0
0
128
1251
1.07
0.13
24.8
15.6
27.8
25.8
mg/l
0.25
111
1030
33
307
1.09
0.13
1.7
1.9
378.2
430.3
pmol/l
0.42
26
254
22
200
1.11
0.13
3.4
3.2
0.8
0.8
mmol/l
0.00
22
180
133
1308
1.05
0.09
30.5
18.2
4.0
4.0
mmol/l
0.43
126
1257
7
64
1.10
0.08
3.1
2.6
4.0
4.5
pmol/l
—
7
55
93
911
1.04
0.07
5.1
4.0
19.6
13.4
mm/h
1.47
81
825
132
1303
1.04
0.06
30.2
18.2
139.7
139.5
mmol/l
0.42
126
1256
71
711
1.00
0.00
8.4
9.0
5.0
4.2
e9/l
2.13
62
618
16
155
1.04
0.00
2.5
3.4
—
—
—
0
0
15
152
0.99
0.00
1.0
1.3
1.3
12.4
u/ml
—
7
66
32
318
1.01
0.00
1.6
1.5
18.6
20.6
nmol/l
0.29
25
256
0
6
0.00
0.00
0.0
1.2
—
12.6
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
219.8
—
0
6
0
6
0.00
0.00
0.0
1.2
—
15.3
—
0
6
8
85
0.94
0.00
1.9
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
7
73
0.96
0.00
1.9
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
6.5
—
0
7
0
5
0.00
0.00
0.0
1.4
—
85.8
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_GLOBEDEGENERATED and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_GLOBEDEGENERATED | 1.333 [1.16, 1.54] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.296 |
During the follow-up period (1.1.1998 — 31.12.2019), 733 out of 1161 females with H7_GLOBEDEGENERATED died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_GLOBEDEGENERATED | 1.488 [1.24, 1.78] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 564 out of 1066 males with H7_GLOBEDEGENERATED died.
Mortality risk
Mortality risk for people of age
years, who have H7_GLOBEDEGENERATED.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.104% | 0.31% |
| 5 | 0.751% | 1.805% |
| 10 | 1.846% | 4.363% |
| 15 | 3.805% | 8.382% |
| 20 | 6.9% | 14.242% |
Relationships between endpoints
↥Index endpoint: H7_GLOBEDEGENERATED – Degenerative conditions of globe
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data